"2025 proved that our technology delivers, not in the distant future, but right now," says Tropic CEO Gilad Gershon.

Researchers at Sanofi report that cas-CLOVER (deactivated Cas9 fused to the C-terminus of Clostridium Clo051) gene editing has the potential to notably enhance recombinant protein production in ...

GERMANTOWN, MD / ACCESS Newswire / March 16, 2026 / uBriGene Biosciences (uBriGene), a global CDMO leader, is excited to announce that its strategic partner, Grit Biotechnologies, has received FDA cle ...

Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...

CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of canc ...

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a cell line development partnership with Score Pharma, Inc., a biopharmaceutical company ...

Proteomics-informed, genome-edited CHO design increased productivity up to three-fold and titers two-fold, strengthening CLD for novel biologics and biosimilars. Extended culture robustness was ...

Scientists create world’s first tomatoes that smell like ‘buttered popcorn’ - Scientists generate world’s first ’extraordinary aromatic tomato plants’ by simultaneously altering two key genes ...

A new study reveals that astrocytes—star-shaped support cells traditionally viewed as passive partners of neurons—play a ...

Northwestern Medicine scientists led by Joseph Bass, MD, Ph.D., the Charles F. Kettering Professor of Endocrinology and Metabolism and director of the Center for Diabetes and Metabolism, have ...

Brains are staggeringly complex. Usually, when we talk about shifting neurodevelopmental traits, we’re looking at years of intensive therapy and complex interventions. But new research from Stanford ...